Trial intelligence / Profile preview

Enzira 2009/2010 seasonal influenza vaccine immunogenicity and safety study in adults and older adults

2009-011450-18Phase 4Completed

Sponsor
CSL Limited
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity and Safety. Started Apr 2009; status: completed.

02

Drugs

omeprazole
03

Conditions

influenza

Beyond the preview

Go deeper on 2009-011450-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011450-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call